CytomX Therapeutics Inc (CTMX)
1.09
-0.01
(-0.91%)
USD |
NASDAQ |
Dec 20, 16:00
1.17
+0.08
(+7.34%)
After-Hours: 05:11
CytomX Therapeutics Market Cap: 85.30M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Spero Therapeutics Inc | 52.32M |
NovaBay Pharmaceuticals Inc | 2.589M |
Palatin Technologies Inc | 18.92M |
iBio Inc | 22.69M |
Theriva Biologics Inc | 3.172M |
Market Cap Related Metrics
PE Ratio | 6.412 |
PS Ratio | 0.7194 |
Price | 1.09 |
Earnings Yield | 15.60% |
Operating PE Ratio | 13.58 |
Normalized PE Ratio | 6.412 |